# Pre-Exposure Prophylaxis for Transgender Women in the US and South America

> **NCT04742491** · PHASE2,PHASE3 · COMPLETED · sponsor: **HIV Prevention Trials Network** · enrollment: 304 (actual)

## Conditions studied

- HIV Prevention

## Interventions

- **DRUG:** Immediate Intervention Arm
- **DRUG:** Deferred Intervention Arm

## Key facts

- **NCT ID:** NCT04742491
- **Lead sponsor:** HIV Prevention Trials Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-26
- **Primary completion:** 2024-08-16
- **Final completion:** 2024-08-16
- **Target enrollment:** 304 (ACTUAL)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04742491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04742491, "Pre-Exposure Prophylaxis for Transgender Women in the US and South America". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04742491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*